Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients
Clinical trial NCT04191213 · UNKNOWN
Trial details
- NCT number
- NCT04191213
- Sponsor
- Al-Neelain University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-15
- Primary completion
- 2020-06-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.